{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-20",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "QYO",
      "openfda": {
        "k_number": [
          "DEN220090"
        ],
        "registration_number": [
          "3004450619"
        ],
        "fei_number": [
          "3004450619"
        ]
      },
      "review_panel": "MG",
      "medical_specialty": "IM",
      "device_name": "Hematopoietic Cell Enrichment Kit ",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Immunology",
      "device_class": "2",
      "definition": "A hematopoietic cell enrichment kit is an in vitro diagnostic device intended for the selection and enrichment of specific hematopoietic cells from human whole blood and/or bone marrow collected from patients with hematological malignancies using immunomagnetic bead-based selection.  It is intended for use with diagnostic assays as part of the pre-analytical workflow.",
      "regulation_number": "866.6120",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}